These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
91 related articles for article (PubMed ID: 18986229)
21. [Molecular pathology and therapeutics in Alzheimer's disease: amyloid beta-protein as a therapeutic target]. Ohyagi Y Fukuoka Igaku Zasshi; 2006 Sep; 97(9):261-8. PubMed ID: 17134029 [No Abstract] [Full Text] [Related]
22. SAR-studies of γ-secretase modulators with PPARγ-agonistic and 5-lipoxygenase-inhibitory activity for Alzheimer's disease. Flesch D; Ness J; Lamers C; Dehm F; Popella S; Steri R; Ogorek I; Hieke M; Dannhardt G; Werz O; Weggen S; Schubert-Zsilavecz M Bioorg Med Chem Lett; 2015 Feb; 25(4):841-6. PubMed ID: 25575659 [TBL] [Abstract][Full Text] [Related]
23. Discovery of a novel series of Notch-sparing gamma-secretase inhibitors. Kreft A; Harrison B; Aschmies S; Atchison K; Casebier D; Cole DC; Diamantidis G; Ellingboe J; Hauze D; Hu Y; Huryn D; Jin M; Kubrak D; Lu P; Lundquist J; Mann C; Martone R; Moore W; Oganesian A; Porte A; Riddell DR; Sonnenberg-Reines J; Stock JR; Sun SC; Wagner E; Woller K; Xu Z; Zhou H; Steven Jacobsen J Bioorg Med Chem Lett; 2008 Jul; 18(14):4232-6. PubMed ID: 18556202 [TBL] [Abstract][Full Text] [Related]
24. Unraveling the tangled brain of Alzheimer's. Wolfson W Chem Biol; 2008 Feb; 15(2):89-90. PubMed ID: 18291309 [No Abstract] [Full Text] [Related]
25. Presenilin: running with scissors in the membrane. Selkoe DJ; Wolfe MS Cell; 2007 Oct; 131(2):215-21. PubMed ID: 17956719 [TBL] [Abstract][Full Text] [Related]
26. Inhibition of gamma-secretase activity reduces Abeta production, reduces oxidative stress, increases mitochondrial activity and leads to reduced vulnerability to apoptosis: Implications for the treatment of Alzheimer's disease. Sheng B; Gong K; Niu Y; Liu L; Yan Y; Lu G; Zhang L; Hu M; Zhao N; Zhang X; Tang P; Gong Y Free Radic Biol Med; 2009 May; 46(10):1362-75. PubMed ID: 19264123 [TBL] [Abstract][Full Text] [Related]
27. Purification, pharmacological modulation, and biochemical characterization of interactors of endogenous human gamma-secretase. Winkler E; Hobson S; Fukumori A; Dümpelfeld B; Luebbers T; Baumann K; Haass C; Hopf C; Steiner H Biochemistry; 2009 Feb; 48(6):1183-97. PubMed ID: 19159235 [TBL] [Abstract][Full Text] [Related]
28. Semagacestat, a gamma-secretase inhibitor for the potential treatment of Alzheimer's disease. Imbimbo BP; Peretto I Curr Opin Investig Drugs; 2009 Jul; 10(7):721-30. PubMed ID: 19579178 [TBL] [Abstract][Full Text] [Related]
29. Molecule of the month. Semagacestat. Drug News Perspect; 2008 Sep; 21(7):390. PubMed ID: 19259551 [No Abstract] [Full Text] [Related]
30. Regulation of secretases by all-trans-retinoic acid. Koryakina A; Aeberhard J; Kiefer S; Hamburger M; Küenzi P FEBS J; 2009 May; 276(9):2645-55. PubMed ID: 19476501 [TBL] [Abstract][Full Text] [Related]
31. Update on amyloid-beta homeostasis markers for sporadic Alzheimer's disease. Zetterberg H Scand J Clin Lab Invest; 2009; 69(1):18-21. PubMed ID: 19199126 [TBL] [Abstract][Full Text] [Related]
32. Pivotal trials for β-secretase inhibitors in Alzheimer's. Sheridan C Nat Biotechnol; 2015 Feb; 33(2):115-6. PubMed ID: 25658256 [No Abstract] [Full Text] [Related]
33. Inhibition of gamma-secretase activity by helical beta-peptide foldamers. Imamura Y; Watanabe N; Umezawa N; Iwatsubo T; Kato N; Tomita T; Higuchi T J Am Chem Soc; 2009 Jun; 131(21):7353-9. PubMed ID: 19432477 [TBL] [Abstract][Full Text] [Related]
34. β-secretase inhibitors for Alzheimer's disease: heading in the wrong direction? Selkoe D Lancet Neurol; 2019 Jul; 18(7):624-626. PubMed ID: 31202466 [No Abstract] [Full Text] [Related]
35. IGF-1 promotes beta-amyloid production by a secretase-independent mechanism. Araki W; Kume H; Oda A; Tamaoka A; Kametani F Biochem Biophys Res Commun; 2009 Feb; 380(1):111-4. PubMed ID: 19167357 [TBL] [Abstract][Full Text] [Related]
36. Design, synthesis and biological evaluation of novel dual inhibitors of acetylcholinesterase and beta-secretase. Zhu Y; Xiao K; Ma L; Xiong B; Fu Y; Yu H; Wang W; Wang X; Hu D; Peng H; Li J; Gong Q; Chai Q; Tang X; Zhang H; Li J; Shen J Bioorg Med Chem; 2009 Feb; 17(4):1600-13. PubMed ID: 19162488 [TBL] [Abstract][Full Text] [Related]
37. Differential effects of gamma-secretase and BACE1 inhibition on brain Abeta levels in vitro and in vivo. Elvang AB; Volbracht C; Pedersen LØ; Jensen KG; Karlsson JJ; Larsen SA; Mørk A; Stensbøl TB; Bastlund JF J Neurochem; 2009 Sep; 110(5):1377-87. PubMed ID: 19519664 [TBL] [Abstract][Full Text] [Related]
38. An alternative spliced mouse presenilin-2 mRNA encodes a novel gamma-secretase inhibitor. Suzuki Y; Ohta K; Itoh M; Sakoh-Sumitomo Y; Mitsuda T; Ueda M; Hayakawa-Yano Y; Li S; Hida Y; Inuzuka T; Jung YK; Nakagawa T FEBS Lett; 2009 May; 583(9):1403-8. PubMed ID: 19376115 [TBL] [Abstract][Full Text] [Related]
39. [Amyloid-beta 42 generating process may have a biological role in regulation of Notch signaling intensity]. Tagami S; Okochi M; Fukumori A; Takeda M Nihon Shinkei Seishin Yakurigaku Zasshi; 2008 Nov; 28(5-6):177-83. PubMed ID: 19108503 [TBL] [Abstract][Full Text] [Related]